Profile data is unavailable for this security.
About the company
Bellevue Healthcare Trust plc is a United Kingdom-based investment trust. The investment objective of the Company is to provide Shareholders with capital growth and income over the long term, through investment in listed or quoted global healthcare companies. The Company invests in a concentrated portfolio of listed or quoted equities in the global healthcare industry. The Company may also invest in American Depositary Receipts (ADRs), or convertible instruments issued by such companies and may invest in, or underwrite, future equity issues by such companies. Its portfolio includes Dental, Diagnostics, Diversified Therapeutics, Focused Therapeutics, Healthcare information technology, Healthcare Technology, Managed Care, Med-Tech, Generics, Services, Tools, Distributors, and others. The Company's investment manager is Bellevue Asset Management (UK) Limited.
- Revenue in GBP (TTM)-41.62m
- Net income in GBP-48.19m
- Incorporated2016
- Employees0.00
- LocationBellevue Healthcare Trust plc4th Floor, 46-48 James StreetLONDON W1U 1EZUnited KingdomGBR
- Phone+44 20 3326 2981
- Websitehttps://www.bellevuehealthcaretrust.com/uk-en/private/
Profile
| Management group(s) | Columbia Threadneedle Investments |
|---|---|
| AIC sector | Biotechnology & Healthcare |
| ISIN | GB00BZCNLL95 |
| Launch date | 02 Dec 2016 |
| Share type | Ordinary Share |
| Structure | Investment Trust |
| Base currency | GBP |
Objective
The investment objective of the Company is to provide shareholders with capital growth and income over the long term, through investment in listed or quoted global healthcare companies. The Company’s specific return objective shall be for its NAV per share (on a total return basis) to beat the total return of the MSCI World Health Care Index (in sterling) on a rolling 3 year period (the index total return including dividends reinvested on a net basis)
Managed by
| Paul Major, Brett Darke |
|---|
Management & contract fees
Management fee payable monthly in arrear and is at the rate of one-twelfth of 0.95% per calendar month of the Market Capitalisation.There is no performance fee payable to Bellevue. The agreement is terminable on 12 months notice.
Peer analysis
| Company | Revenue (TTM) | Net income (TTM) |
|---|---|---|
| Mobius Investment Trust PLC | -681.00k | -4.19m |
| EJF Investments Ltd | 5.73m | 1.53m |
| Triple Point Venture VCT PLC | 2.66m | 187.00k |
| Barings Emerging Emea Opportunities PLC | 24.60m | 23.01m |
| Golden Prospect Precious Metals Ltd. | 24.79m | 23.57m |
| Rights and Issues Investment Trust PLC | 571.00k | -695.00k |
| JPMorgan Emng Erp Mdl Est&Afrc Scrts PLC | 6.39m | 5.39m |
| Global Opportunities Trust PLC | 6.95m | 5.76m |
| Bellevue Healthcare Trust PLC | -41.62m | -48.19m |
| Octopus AIM VCT plc | -6.48m | -9.12m |
| Molten Ventures VCT PLC | 1.70m | -1.35m |
| India Capital Growth Fund Ltd | 415.00k | -8.47m |
| abrdn European Logistics Income PLC | 36.00m | 7.21m |
| JZ Capital Partners Limited | -491.59k | -4.86m |
| Baker Steel Resources Trust Ltd | 26.74m | 24.89m |
Institutional shareholders
| Holder | Shares | % Held |
|---|---|---|
| Brewin Dolphin Ltd.as of 28 Feb 2025 | 15.29m | 15.43% |
| EFG Private Bank Ltd.as of 28 Feb 2025 | 13.73m | 13.87% |
| BMO Asset Management, Inc.as of 23 Sep 2024 | 11.10m | 11.21% |
| Brooks Macdonald Asset Management Ltd.as of 28 Feb 2025 | 8.86m | 8.95% |
| Evelyn Partners Investment Management LLPas of 16 Oct 2025 | 5.69m | 5.74% |
| RBC Europe Ltd.as of 05 Nov 2025 | 5.37m | 5.43% |
| BlackRock Investment Management (UK) Ltd.as of 31 Oct 2025 | 4.29m | 4.33% |
| J. M. Finn & Co. Ltd.as of 26 Nov 2025 | 3.56m | 3.59% |
| Jefferies International Ltd. (Investment Management)as of 23 Jul 2025 | 2.39m | 2.41% |
| Handelsbanken Wealth & Asset Management Ltd.as of 31 Dec 2024 | 2.29m | 2.31% |
